Assessment of Efficacy and Safety of Metabolic Therapy With Trimetazidine MB in Patients With Ischemic Heart Disease and Chronic Heart Failure

Study purpose - to assess clinical and hemodynamic parameters in patients with ischemic heart disease (IHD) with and without use of metabolic therapy with trimetazidine MB. Seventy four patients with IHD, 40 of whom in addition to the main therapy for 3 months received metabolic preparation trimetaz...

Full description

Saved in:

Bibliographic Details
Published in:	Kardiologiia Vol. 56; no. 3; p. 67
Main Authors:	Gorbunova, M L, Vilkova, A V
Format:	Journal Article
Language:	Russian
Published:	Russia (Federation) 01-03-2016
Subjects:	Chronic Disease Female Hemodynamics Humans Male Middle Aged Myocardial Ischemia - drug therapy Trimetazidine - therapeutic use Vasodilator Agents - therapeutic use
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Study purpose - to assess clinical and hemodynamic parameters in patients with ischemic heart disease (IHD) with and without use of metabolic therapy with trimetazidine MB. Seventy four patients with IHD, 40 of whom in addition to the main therapy for 3 months received metabolic preparation trimetazidine MB. Number of anginal attacks and inhalations of nitroglycerin significantly decreased and parameters of hemodynamics improved after 3 months in patients who received trimetazidine MB. Long-term use of trimetazidine MB in patients with IHD is advisable.
ISSN:	0022-9040
DOI:	10.18565/cardio.2016.3.67-72